The Clinical Trend of Leprosy from 2000 to 2016 in Kaohsiung, a Major International Harbor City in Taiwan, Where Leprosy is Almost Eradicated

Jpn J Infect Dis. 2021 Mar 24;74(2):110-114. doi: 10.7883/yoken.JJID.2020.160. Epub 2020 Aug 31.

Abstract

Leprosy is a socially stigmatized granulomatous skin disease caused by Mycobacterium leprae. Due to improvements in medicine and hygiene in Taiwan, the incidence is very low, up to one dozen per year; however, leprosy has never been eradicated due to the increased numbers of immigrants from Southeast Asia. This study aimed to characterize the clinical and histopathological features of patients with leprosy in the context of near elimination. Fifteen cases of pathologically proven leprosy were identified from 2000 to 2016 in Kaohsiung Chang Gung Memorial Hospital. The clinical presentations, demographic details, treatment responses, and disease outcomes were reviewed. The mean age was 46 years (range: 26-73 years). Eight cases were native Taiwanese, while 6 cases and 1 case involved foreign workers from Indonesia and Thailand, respectively. The diagnosis was made 3-6 months on average after skin lesions appeared. The most common clinical subtype was lepromatous leprosy (n = 7). Ten patients were multibacillus microscopically. Three cases were deported. The remaining 12 patients received dapsone and rifampicin for 12 months without recurrence to date. In the near leprosy-eradicated country, early diagnosis and physician vigilance are critical in disease control. Immigrants from endemic countries require strict and professional dermatological examinations and regular follow-up.

Keywords: Mycobacterium leprae; granulomatous disease; leprosy.

MeSH terms

  • Adult
  • Aged
  • Dapsone / therapeutic use
  • Disease Eradication
  • Female
  • Humans
  • Leprosy / epidemiology*
  • Leprosy / pathology
  • Leprosy / prevention & control*
  • Leprosy, Lepromatous / epidemiology
  • Male
  • Middle Aged
  • Mycobacterium leprae / isolation & purification
  • Retrospective Studies
  • Rifampin / therapeutic use
  • Skin / pathology
  • Taiwan / epidemiology

Substances

  • Dapsone
  • Rifampin